Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
Title:
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
Author:
Burns, Jane C Roberts, Samantha C Tremoulet, Adriana H He, Feng Printz, Beth F Ashouri, Negar Jain, Supriya S Michalik, David E Sharma, Kavita Truong, Dongngan T Wood, James B Kim, Katherine K Jain, Sonia
Appeared in:
The Lancet child & adolescent health
Paging:
Volume 5 () nr. 12 pages 852-861
Year:
2021
Contents:
Publisher:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 4.0 license